5/10
09:21 am
rlay
Rating for RLAY
Medium
Report
Rating for RLAY
5/10
09:21 am
rlay
Rating for RLAY
Medium
Report
Rating for RLAY
5/10
08:11 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $15.00 price target on the stock.
Low
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $15.00 price target on the stock.
5/6
11:54 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
Low
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
5/6
11:54 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
Low
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $24.00 price target on the stock.
5/6
11:05 am
rlay
Rating for RLAY
Low
Report
Rating for RLAY
5/6
11:05 am
rlay
Rating for RLAY
Low
Report
Rating for RLAY
5/6
08:05 am
rlay
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $25.00 price target on the stock, down previously from $33.00.
Low
Report
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $25.00 price target on the stock, down previously from $33.00.
5/6
07:57 am
rlay
Rating for RLAY
Medium
Report
Rating for RLAY
5/6
07:57 am
rlay
Rating for RLAY
Medium
Report
Rating for RLAY